JOURNAL BROWSE
Search
Advanced SearchSearch Tips
p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence
facebook(new window)  Pirnt(new window) E-mail(new window) Excel Download
 Title & Authors
p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence
Sawair, F; Hassona, Y; Irwin, C; Stephenson, M; Hamilton, P; Maxwell, P; Gordon, D; Leonard, A; Napier, S;
  PDF(new window)
 Abstract
Background: Expression of p53, cyclin D1, p21 (WAF1) and Ki-67 (MIB1) was evaluated in oral squamous cell carcinoma (OSCC) to test whether levels of these markers at invasive tumour fronts (ITFs) could predict the development of local recurrence. Materials and Methods: Archived paraffin-embedded specimens from 51 patients with T1/T2 tumours were stained immunohistochemically and analysed quantitatively. Local recurrence-free survival was tested with Kaplan-Meier survival plots (log-rank test) using median values to define low and high expression groups and with a Cox`s proportional hazards model in which the expression scores were entered as continuous variables. Results: The assessment of expression of all markers was highly reliable, univariate analysis showing that patients with clear surgical margins, with low cyclin D1 and high p21 expression at the ITF had the best local recurrence-free survival. Multivariate analysis showed that these three parameters were independent prognostic factors but that neither p53 nor MIB1 expression were of prognostic value. Conclusions: Assessment of p53, cyclin D1, p21 (WAF1), and Ki-67 (MIB1) at the ITF could help to predict local recurrence in early stage oral squamous cell carcinoma cases.
 Keywords
Immunohistochemistry;oral squamous cell carcinoma;p53;cyclin D1;p21 (WAF1);Ki-67 (MIB1);
 Language
English
 Cited by
 References
1.
Altman DG, Lausen B, Sauerbrei W, et al (1994). Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst, 86, 829-35. crossref(new window)

2.
Bryne M (1998). Is the invasive front of an oral carcinoma the most important area for prognostication? Oral Dis, 4, 70-7.

3.
Dissanayaka WL, Pitiyage G, Kumarasiri PV, et al (2012). Clinical and histopathologic parameters in survival of oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol, 113, 518-25. crossref(new window)

4.
Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008, GLOBOCAN 2008. Int J Cancer, 127, 2893-917. crossref(new window)

5.
Ferlay J, Soerjomataram I, Ervik M, Dikshit R, et al (2013). GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide, IARC cancer base No. 11 [Internet]. Lyon, France, International Agency for Research on Cancer.

6.
Pisani P, Parkin DM, Ferlay J (1993). Estimates of the worldwide mortality from eighteen major cancers in 1985. Implications for prevention and projections of future burden. Int J Cancer, 55, 891-903. crossref(new window)

7.
Harada K, Ogden GR (2000). An overview of the cell cycle arrest protein, p21 (WAF1). Oral Oncol, 36, 3-7. crossref(new window)

8.
Hassan NM, Hamada J, Kameyama T, et al (2011). Increased expression of the PRL-3 gene in human oral squamous cell carcinoma and dysplasia tissues. Asian Pac J Cancer Prev, 12, 947-51.

9.
Heah KG, Hassan MI, Huat SC (2011). p53 Expression as a marker of microinvasion in oral squamous cell carcinoma. Asian Pac J Cancer Prev, 12, 1017-22.

10.
Hermanek P, Sobin LH (1987) International Union Against Cancer (UICC). TNM classification of malignant tumours. Berlin, Springer-Verlag.

11.
Kato H, Yoshikawa M, Fukai Y, et al (2000). An immunohistochemical study of p16, pRb, p21 and p53 proteins in human esophageal cancers. Anticancer Res, 20, 345-9.

12.
Kato K, Kawashiri S, Yoshizawa K, et al (2011). Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma, correlation with clinicopathological features and prognosis. J Oral Pathol Med, 40, 693-8. crossref(new window)

13.
Khunamornpong S, Settakorn J, Sukpan K, et al (2013). Prognostic value of pathological characteristics of invasive margins in early-stage squamous cell carcinomas of the uterine cervix. Asian Pac J Cancer Prev, 14, 5165-9. crossref(new window)

14.
Kilickap S, Kaya Y, Yucel B, et al (2014). Higher Ki67 expression is associates with unfavorable prognostic factors and shorter survival in breast cancer. Asian Pac J Cancer Prev, 15, 1381-5. crossref(new window)

15.
King H, Nicholas NS, Wells CM (2014). Role of p-21-activated kinases in cancer progression. Int Rev Cell Mol Biol, 309, 347-87. crossref(new window)

16.
Li LT, Jiang G, Chen Q, et al (2015). Ki67 is a promising molecular target in the diagnosis of cancer. Mol Med Rep, 11, 1566-72.

17.
Mahdey HM, Ramanathan A, Ismail SM, et al (2011). Cyclin D1 amplification in tongue and cheek squamous cell carcinoma. Asian Pac J Cancer Prev, 12, 2199-204.

18.
Malone JP, Stephens JA, Grecula JC, et al (2004). Disease control, survival, and functional outcome after multimodal treatment for advanced-stage tongue base cancer. Head Neck, 26, 561-72. crossref(new window)

19.
Malumbres M (2014). Cyclin-dependent kinases. Genome Biol, 15, 122. crossref(new window)

20.
Manchanda A, Shetty DC (2012). Reproducibility of grading systems in oral epithelial dysplasia. Med Oral Patol Oral Cir Bucal, 17, 935-42.

21.
Marcel V, Catez F, Diaz JJ (2015). p53, a translational regulator, contribution to its tumour-suppressor activity. Oncogene, 34, 5513-23 crossref(new window)

22.
Mosmann JP, Monetti MS, Frutos MC, et al (2015). Mutation detection of E6 and LCR genes from HPV 16 associated with carcinogenesis. Asian Pac J Cancer Prev, 16, 1151-7. crossref(new window)

23.
Patel KR, Vajaria BN, Begum R, et al (2013). Association between p53 gene variants and oral cancer susceptibility in population from Gujarat, West India. Asian Pac J Cancer Prev, 14, 1093-100. crossref(new window)

24.
Petric M, Martinez S, Acevedo F, et al (2014). Correlation between Ki67 and histological grade in breast cancer patients treatedwith preoperative chemotherapy. Asian Pac J Cancer Prev, 15, 10277-80.

25.
Rane CK, Minden A (2014). P21 activated kinases, structure, regulation, and functions. Small GTPases, 5, 28003. crossref(new window)

26.
Rivera C, Venegas B (2014). Histological and molecular aspects of oral squamous cell carcinoma (Review). Oncol Lett, 8, 7-11.

27.
Sabattini E, Bisgaard K, Ascani S, et al (1998). The EnVision system, a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol, 51, 506-11. crossref(new window)

28.
Schliephake H (2003). Prognostic relevance of molecular markers of oral cancer-a review. Int J Oral Maxillofac Surg, 32, 233-45. crossref(new window)

29.
Shin MK, Kim JW (2014). Clinicopathologic and diagnostic significance of p53 protein expression in papillary thyroid carcinoma. Asian Pac J Cancer Prev, 15, 2341-4. crossref(new window)

30.
Shinohara S, Kikuchi M, Tona R, et al (2014). Prognostic impact of p16 and p53 expression in oropharyngeal squamous cell carcinomas. Jpn J Clin Oncol, 44, 232-40. crossref(new window)

31.
Silva Junior Jde A, Camisasca DR, Bernardo V, et al (2013). The significance of p53 immunoexpression with different clones (DO-7 and PAb-240) in oral squamous cell carcinoma. ORL J Otorhinolaryngol Relat Spec, 75, 82-90. crossref(new window)

32.
Taghavi N, Biramijamal F, Sotoudeh M, et al (2010). Association of p53/p21 expression with cigarette smoking and prognosis in esophageal squamous cell carcinoma patients. World J Gastroenterol, 16, 4958-67. crossref(new window)

33.
Verma R, Singh A, Jaiswal R, et al (2014). Association of Ki-67 antigen and p53 protein at invasive tumor front of oral squamous cell carcinoma. Indian J Pathol Microbiol, 57, 553-7. crossref(new window)

34.
Yan J, Liu XL, Han LZ, et al (2015). Relation between Ki-67, ER, PR, Her2/neu, p21, EGFR, and TOP II-${\alpha}$ expression in invasive ductal breast cancer patients and correlations with prognosis. Asian Pac J Cancer Prev, 16, 823-9. crossref(new window)